一个新的功能基因锌指蛋白485 (ZNF485)参与膀胱癌的增殖

IF 1 4区 医学 Q4 ONCOLOGY
Bladder Cancer Pub Date : 2022-04-24 DOI:10.3233/blc-211623
Yiao Tan, Fangfang Zhao, Shuhan Liu, Tao Huang, Chunbao Zang, Dan Sha, Lingsuo Kong, Fangfang Ge, Dabing Huang, Youguang Pu
{"title":"一个新的功能基因锌指蛋白485 (ZNF485)参与膀胱癌的增殖","authors":"Yiao Tan, Fangfang Zhao, Shuhan Liu, Tao Huang, Chunbao Zang, Dan Sha, Lingsuo Kong, Fangfang Ge, Dabing Huang, Youguang Pu","doi":"10.3233/blc-211623","DOIUrl":null,"url":null,"abstract":"<h4><span>Abstract</span></h4><h3><span></span>BACKGROUND:</h3><p>Bladder cancer is the second most common urological cancer worldwide, with low early diagnosis and high mortality. The limited progress in diagnostics and treatment greatly impedes the survival of bladder cancer patients.</p><h3><span></span>OBJECTIVE:</h3><p>Potential therapeutic biomarkers are urgently needed for future clinical treatment.</p><h3><span></span>METHODS:</h3><p>We analyzed the sequencing data and corresponding clinicopathological features and survival information of bladder cancer patients in the TCGA database and identified a new zinc finger protein 485 gene, termed ZNF485, which is highly expressed in the tissues of bladder cancer patients and was verified in cells, animal models and tissue microarrays.</p><h3><span></span>RESULTS:</h3><p>We found that inhibition of ZNF485 in the bladder cancer cell lines T24 and 5637 obviously inhibited proliferation and promoted the apoptosis of cancer cells. Furthermore, wound healing and invasion assays showed that downregulation of ZNF485 significantly decreased the mobility and invasion of T24 and 5637 cells. In addition, ZNF485-shRNA transfection obviously inhibited tumor growth in nude mice. Immunohistochemical results of clinical samples showed that the expression level of ZNF485 protein in cancer tissues was higher than that in adjacent tissues. Mechanistic analysis identified possible downstream target genes.</p><h3><span></span>CONCLUSIONS:</h3><p>Taken together, the results provide evidence that ZNF485 is involved in bladder cancer proliferation and might be a potential therapeutic biomarker for the treatment of this disease</p>","PeriodicalId":54217,"journal":{"name":"Bladder Cancer","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2022-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A New Functional Gene, Zinc Finger Protein 485 (ZNF485), is Involved in Bladder Cancer Proliferation\",\"authors\":\"Yiao Tan, Fangfang Zhao, Shuhan Liu, Tao Huang, Chunbao Zang, Dan Sha, Lingsuo Kong, Fangfang Ge, Dabing Huang, Youguang Pu\",\"doi\":\"10.3233/blc-211623\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<h4><span>Abstract</span></h4><h3><span></span>BACKGROUND:</h3><p>Bladder cancer is the second most common urological cancer worldwide, with low early diagnosis and high mortality. The limited progress in diagnostics and treatment greatly impedes the survival of bladder cancer patients.</p><h3><span></span>OBJECTIVE:</h3><p>Potential therapeutic biomarkers are urgently needed for future clinical treatment.</p><h3><span></span>METHODS:</h3><p>We analyzed the sequencing data and corresponding clinicopathological features and survival information of bladder cancer patients in the TCGA database and identified a new zinc finger protein 485 gene, termed ZNF485, which is highly expressed in the tissues of bladder cancer patients and was verified in cells, animal models and tissue microarrays.</p><h3><span></span>RESULTS:</h3><p>We found that inhibition of ZNF485 in the bladder cancer cell lines T24 and 5637 obviously inhibited proliferation and promoted the apoptosis of cancer cells. Furthermore, wound healing and invasion assays showed that downregulation of ZNF485 significantly decreased the mobility and invasion of T24 and 5637 cells. In addition, ZNF485-shRNA transfection obviously inhibited tumor growth in nude mice. Immunohistochemical results of clinical samples showed that the expression level of ZNF485 protein in cancer tissues was higher than that in adjacent tissues. Mechanistic analysis identified possible downstream target genes.</p><h3><span></span>CONCLUSIONS:</h3><p>Taken together, the results provide evidence that ZNF485 is involved in bladder cancer proliferation and might be a potential therapeutic biomarker for the treatment of this disease</p>\",\"PeriodicalId\":54217,\"journal\":{\"name\":\"Bladder Cancer\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2022-04-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bladder Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3233/blc-211623\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bladder Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3233/blc-211623","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

摘要背景:膀胱癌是全球第二大泌尿系统肿瘤,早期诊断低,死亡率高。诊断和治疗进展有限,极大地阻碍了膀胱癌患者的生存。目的:未来临床迫切需要潜在的治疗性生物标志物。方法:我们分析TCGA数据库中膀胱癌患者的测序数据及相应的临床病理特征和生存信息,鉴定出一个新的锌指蛋白485基因,命名为ZNF485,该基因在膀胱癌患者组织中高表达,并在细胞、动物模型和组织芯片上进行了验证。结果:我们发现抑制ZNF485在膀胱癌细胞株T24和5637中明显抑制癌细胞增殖,促进癌细胞凋亡。此外,伤口愈合和侵袭实验表明,下调ZNF485可显著降低T24和5637细胞的移动性和侵袭性。此外,转染ZNF485-shRNA可明显抑制裸鼠肿瘤生长。临床标本免疫组化结果显示,ZNF485蛋白在癌组织中的表达水平高于癌旁组织。机制分析确定了可能的下游靶基因。结论:综上所述,这些结果提供了ZNF485参与膀胱癌增殖的证据,并可能成为治疗该疾病的潜在治疗性生物标志物
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A New Functional Gene, Zinc Finger Protein 485 (ZNF485), is Involved in Bladder Cancer Proliferation

Abstract

BACKGROUND:

Bladder cancer is the second most common urological cancer worldwide, with low early diagnosis and high mortality. The limited progress in diagnostics and treatment greatly impedes the survival of bladder cancer patients.

OBJECTIVE:

Potential therapeutic biomarkers are urgently needed for future clinical treatment.

METHODS:

We analyzed the sequencing data and corresponding clinicopathological features and survival information of bladder cancer patients in the TCGA database and identified a new zinc finger protein 485 gene, termed ZNF485, which is highly expressed in the tissues of bladder cancer patients and was verified in cells, animal models and tissue microarrays.

RESULTS:

We found that inhibition of ZNF485 in the bladder cancer cell lines T24 and 5637 obviously inhibited proliferation and promoted the apoptosis of cancer cells. Furthermore, wound healing and invasion assays showed that downregulation of ZNF485 significantly decreased the mobility and invasion of T24 and 5637 cells. In addition, ZNF485-shRNA transfection obviously inhibited tumor growth in nude mice. Immunohistochemical results of clinical samples showed that the expression level of ZNF485 protein in cancer tissues was higher than that in adjacent tissues. Mechanistic analysis identified possible downstream target genes.

CONCLUSIONS:

Taken together, the results provide evidence that ZNF485 is involved in bladder cancer proliferation and might be a potential therapeutic biomarker for the treatment of this disease

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Bladder Cancer
Bladder Cancer Medicine-Urology
CiteScore
1.60
自引率
0.00%
发文量
35
期刊介绍: Bladder Cancer is an international multidisciplinary journal to facilitate progress in understanding the epidemiology/etiology, genetics, molecular correlates, pathogenesis, pharmacology, ethics, patient advocacy and survivorship, diagnosis and treatment of tumors of the bladder and upper urinary tract. The journal publishes research reports, reviews, short communications, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research in basic science, translational research and clinical medicine that expedites our fundamental understanding and improves treatment of tumors of the bladder and upper urinary tract.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信